Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Do the Challenges Outweigh the Potential of Using ChatGPT in CDI?

Chat GPT in CDI (Clinical Documentation Integrity) is real. In the rapidly evolving realm of artificial intelligence (AI), the chatter has reached a fever pitch around the potential uses of ChatGPT, OpenAI’s conversational AI model. Since its unveiling in November 2022, advocates have championed the technology’s potential in sectors as varied as healthcare,…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Iodine Software on MarketScale.

Share
Do the Challenges Outweigh the Potential of Using ChatGPT in CDI?

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Chat GPT in CDI (Clinical Documentation Integrity) is real. In the rapidly evolving realm of artificial intelligence (AI), the chatter has reached a fever pitch around the potential uses of ChatGPT, OpenAI’s conversational AI model. Since its unveiling in November 2022, advocates have championed the technology’s potential in sectors as varied as healthcare, marketing, law, and education. The Clinical Documentation Integrity (CDI) space is in the crosshairs of this discussion, especially as AI continues to reshape healthcare delivery. There are already concerns about potential malpractice risks associated with the use of AI. Still, the question remains: can ChatGPT in CDI solve all its related issues and challenges?

The Iodine Intelligence podcast, hosted by Iodine Software’s Marketing Manager, Lauren Hickey, grapples with this timely question. Hickey’s guest, Fran Jurcak, Chief Clinical Officer at Iodine Software, joined the conversation to dissect the implications of ChatGPT in CDI.

Hickey and Jurcak discuss the following:

  • The capabilities and limitations of ChatGPT and its underlying Natural Language Processing (NLP) technology in the context of CDI
  • The potential issues with the biases inherent in AI technologies, including ChatGPT
  • The future possibilities for CDI through a blend of AI technologies and whether ChatGPT could play a role in that solution

Fran Jurcak, a seasoned healthcare leader and the Chief Clinical Officer at Iodine Software, brings a wealth of knowledge and experience to this conversation. Known for her clinical strategy expertise, Jurcak has been instrumental in exploring and applying AI’s potential within the CDI landscape, leveraging her rich background in healthcare, nursing, and technology to chart a forward-thinking path for Iodine Software.

ChatGPT’s potential in CDI is a complex issue, as the conversation reveals. While the technology’s ability to generate original content based on a user’s request shows promise, its limitations—specifically, its inability to interpret information contextually and identify missing data—pose significant challenges, including whether or not physicians will meticulously check the work for accuracy. Moreover, the AI’s existing biases, fueled by the online textual data used for training, could present serious ethical implications when applied to medical documentation. According to Jurcak, while ChatGPT alone may not be the magic bullet for CDI, its integration with other AI technologies could open new avenues for innovation in the future.

Iodine Software

Part of this channel

Iodine Software

AI-powered clinical documentation that helps hospitals capture accurate revenue.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits now take 3–5+ years of prep. Dental Economics says associate-to-buyout timelines often run three to five-plus years. That pushes revenue-cycle controls, buy-sell terms, and tax structure earlier, before a buyer appears.

  • 01A practical benchmark is emerging for succession: bringing in an associate with intent to buy can take a minimum of three years and often more than five, according to Dental Economics.
  • 02If accounts receivable looks “high,” it may be a bookkeeping and posting problem before it is a payer problem, a revenue-cycle diagnostic Group Dentistry Now says shows up frequently at scale.
  • 03Exit planning is now an operating system project: valuation, tax positioning, and transition support belong in the same workstream, because deal structure can lock in or foreclose tax options, per Dental Economics.

Sep 4, 2026

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com closed $220 million in equity and debt. It’s expanding its U.S. imaging network plus API-based scheduling and results delivery. For health plans and employers, imaging is starting to look like a platform procurement and integration decision, not a directory problem.

  • 01If imaging access is bought via an API, the real spec becomes integration depth: two-way scheduling plus results routing into the EMR, according to Business Wire.
  • 02Scan.com’s mix of $90M equity and $130M debt earmarked for M&A and working capital points to a fast-changing imaging provider network, which can help access but demands discipline in contracting and integration testing.
  • 03The same week’s funding news for Elucid ($55M) suggests AI imaging vendors will keep pushing toward FDA-cleared workflow insertions, a different buying path than network-layer platforms.

Sep 4, 2026

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitor messaging suggests compliance testing and AI-ready compute are becoming early decisions, not afterthoughts. Medical Economics described 2026 as a period shaped by rapid technological change, regulatory scrutiny and ongoing economic uncertainty. Medical Design & Outsourcing’s MD&M West 2026 preview points to exhibitors highlighting test equipment, contract manufacturing and other launch support services.

  • 01If a device roadmap includes AI features, the critical path shifts toward data and software evidence that regulators can audit, which means earlier lock-in of compute platforms and test plans, pulling verification and validation into supplier selection.
  • 02MD&M West exhibitor messaging suggests verification and validation capacity is becoming a procurement problem, with rentals and lab-ready gear positioned as a way to avoid booking delays and re-tests, according to Medical Design & Outsourcing.
  • 03With imaging and other new procedural and device concepts moving fast, manufacturing leaders should expect more frequent line-change decisions and component qualification work, as GE HealthCare's photon-counting CT CE mark reported by MedTech Dive and MDDI's New Technologies coverage illustrate.

Sep 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512